摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Methyl-5-thiophen-2-yl-2H-pyrazole-3-carboxylic acid | 890621-27-9

中文名称
——
中文别名
——
英文名称
4-Methyl-5-thiophen-2-yl-2H-pyrazole-3-carboxylic acid
英文别名
4-methyl-5-thiophen-2-yl-1H-pyrazole-3-carboxylic acid
4-Methyl-5-thiophen-2-yl-2H-pyrazole-3-carboxylic acid化学式
CAS
890621-27-9
化学式
C9H8N2O2S
mdl
MFCD20356310
分子量
208.24
InChiKey
RZFZFQSJPCUVII-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.111
  • 拓扑面积:
    94.2
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 危险等级:
    IRRITANT

文献信息

  • LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY
    申请人:Graffinity Pharmaceuticals GmbH
    公开号:EP2601208A2
    公开(公告)日:2013-06-12
  • [EN] LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY<br/>[FR] LIGANDS POUR LA PURIFICATION D'ANTICORPS ET DE PROTÉINE DE FUSION À FC PAR CHROMATOGRAPHIE D'AFFINITÉ
    申请人:GRAFFINITY PHARMACEUTICALS GMBH
    公开号:WO2012017021A2
    公开(公告)日:2012-02-09
    The present invention relates to the use for affinity purification of an antibody or an fragment of an antibody, of a ligand-substituted matrix comprising a support material and at least one ligand covalently bonded to the support material, the ligand being represented by formula (I) wherein Sp is a spacer group; v is 0 or 1; Am is an amide group -NR1-C(O)-, and wherein either NR1 is attached to Ar1 and C(O)- is attached to Ar2, or -C(O)- is attached to Ar1 and NR1 is attached to Ar2; and R1 is hydrogen or C1 to C4 alkyl, preferably hydrogen or methyl; and more preferably hydrogen; Ar1 is a divalent 5- or 6-membered substituted or unsubstituted aromatic ring; Ar2 is 5- or 6-membered heterocyclic aromatic ring which is (a) attached to a further 5- or 6-membered aromatic ring via a single bond; or (b) fused to a further 5- or 6-membered aromatic ring as part of a multicyclic ring system; or (c) attached to at least one substituent selected from C1 to C4 alkyl; C2 to C4 alkenyl; C2 to C4 alkynyl; a halogen; C1 to C4 haloalkyl; hydroxyl-substituted C1 to C4 alkyl; C1 to C4 alkoxy; hydroxyl-substituted C1 to C4 alkoxy; C1 to C4 alkylamino; C1 to C4 alkylthio; and combinations thereof.
查看更多